Registered Nurse in Holmen, WI Accepting Medicare

8 Registered Nurse nurses found. Showing 1 - 8

Ashley Ann Rezin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1006 Remington Dr, Holmen, WI 54636 Phone: 608-797-0710

Sara Smitherman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: N7219 Leibl Ct, Holmen, WI 54636 Phone: 507-884-9185

Misty Dawn Schindler, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1005 Deerfield St, Holmen, WI 54636 Phone: 608-769-8762

Sarah K Bone, RN BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 505 Evergreen Dr, Holmen, WI 54636 Phone: 608-769-1189

Karol Ivera Smith, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 811 Saddlewood St, Holmen, WI 54636 Phone: 608-769-1270

Mrs. Theresa Margaret Hartung, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: N7052 Sunrise Ln, Holmen, WI 54636 Phone: 608-769-8772

Patricia Lynn Mathison, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 206 Park Ln, Holmen, WI 54636 Phone: 608-797-8882

Mrs. Jennifer Koop, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: N8565 Holseth Rd, Holmen, WI 54636 Phone: 608-526-2878

News Archive

First Edition: September 5, 2014

Today's headlines include reports of hacker activity at the healthcare.gov health insurance website.

Local ordinances in Appalachian states do not offer protection against second-hand smoke: Study

Local ordinances in Appalachian states with weak statewide smoking regulations do not offer most residents adequate protection against second-hand smoke, according to a new study.

New prospective payment system contributes to improved patient choice, quality of care and costs

AcademyHealth today awarded its Health Services Research (HSR) Impact Award to work that contributed to the development of a prospective payment system that contributed to improved patient choice and quality of care, and reduced costs in the treatment of End Stage Renal Disease (ESRD).

Seattle Genetics starts trial of SGN-35 for anaplastic large cell lymphoma

Seattle Genetics, Inc. (NASDAQ:SGEN), has announced that it has initiated a phase II clinical trial of SGN-35 for patients with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). SGN-35 is an antibody-drug conjugate (ADC) that utilizes Seattle Genetics' proprietary technology to empower antibodies by linking them to potent cell-killing drugs.

Gladstone scientists bioengineer micro-scale heart tissues from stem cells

Scientists at the Gladstone Institutes have invented a new way to create three-dimensional human heart tissue from stem cells. The tissue can be used to model disease and test drugs, and it opens the door for a precision medicine approach to treating heart disease. Although there are existing techniques to make three-dimensional tissues from heart cells, the new method dramatically reduces the number of cells needed, making it an easier, cheaper, and more efficient system.

Read more Medical News

› Verified 2 days ago